Pharmaceuticals, Biotechnology and Life Sciences
—Designation Follows Recently Reported PHYOX™1 Phase 1 Data Showing Positive Clinical Responses to DCR-PHXC— —FDA Recognizes Primary Hyperoxaluria Types 2…
– KVD900 Enrolling Phase 2 Clinical Trial for Oral Treatment of Hereditary Angioedema (HAE) with Data Expected in Late 2019…
– Original metastatic castration-resistant prostate cancer and immunotherapy-refractory non-small cell lung cancer cohorts expanded to 80 subjects – – Four…
– Professor Jacky Smith from the University of Manchester to lead live webcast – LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX:…
– 87% reduction in average number of Gb3 inclusions in first kidney biopsy taken one year post-treatment, the primary efficacy…
EMERYVILLE, Calif.–(BUSINESS WIRE)–#Avenova—NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care…
DUBLIN–(BUSINESS WIRE)–The “Asthma and COPD Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to…
– Data demonstrate statistically significant biomarker activity at well-tolerated dose in PKU patients – – Plan to initiate bridging study…
First and only FDA-approved sprinkle formulation of rosuvastatin Extended-release-coated granules designed to facilitate once-daily administration especially for the 30-35% of…
– Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment – – Gilead Gains Access to Galapagos’…